Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jessica Kano"'
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 1761-1772 (2022)
Background: Palbociclib, a cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitor, in combination with letrozole or fulvestrant has been demonstrated to prolong the progression-free survival (PFS) in patients with hormone receptor-positive (HR+), human
Externí odkaz:
https://doaj.org/article/6992f67fff3a412e84fc031e50b07573
Autor:
Joy Florendo, Brian Higgins, Tiffany Marr-Del Monte, Mova Leung, Jessica Kano, Glenn Jones, Trishala Menon, Robert Myers
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 23(6)
The short half-life of filgrastim allows for modification in the dose or duration of prophylaxis to limit inconvenience, adverse effects, and cost. The objectives of this study were to characterize and compare pain and neutropenic events between filg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b56f55c3c72de5cef4efb3c96d06e46
https://pubmed.ncbi.nlm.nih.gov/25421443
https://pubmed.ncbi.nlm.nih.gov/25421443
Autor:
Mova Leung, Robert Myers, Joy Eustaquio, Jessica Kano, Glenn Jones, Brian Patrick Higgins, Tiffany Marr, Jenny J. Kim
Publikováno v:
Journal of Clinical Oncology. 30:e19570-e19570
e19570 Background: In comparative trials of P and F, bone and joint pain are evident and with similar incidences. Also, muscle pain is clinically noted. Pain severity may differ between P and F, especially when a short fixed-dose regimen of F is used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89420ec93d58e0386be2de328148babe
https://doi.org/10.1200/jco.2012.30.15_suppl.e19570
https://doi.org/10.1200/jco.2012.30.15_suppl.e19570